Xiao-Kun Ma
Overview
Explore the profile of Xiao-Kun Ma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
598
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma X, Liu T, Ren Y, Ma X, Yao Y, Hou X, et al.
Acta Pharmacol Sin
. 2023 Sep;
45(2):436-448.
PMID: 37749238
Extracellular matrix metalloproteinase inducer CD147 is a glycoprotein on the cell surface. There is minimal expression of CD147 in normal epithelial and fetal tissues, but it is highly expressed in...
2.
Li L, Ma X, Gao Y, Wang D, Dong R, Yan J, et al.
World J Clin Cases
. 2023 Sep;
11(25):5910-5918.
PMID: 37727493
Background: Malignant peripheral nerve sheath tumor (MPNST) is a rare and aggressive soft tissue sarcoma that poses a major diagnostic and therapeutic challenge. Case Summary: We retrospectively reviewed patients with...
3.
Liu M, Chen Z, Zhao L, Zhao J, Rong D, Ma X, et al.
Oncol Res Treat
. 2021 Aug;
44(9):450-468.
PMID: 34380137
Introduction: The prognosis of advanced hepatocellular carcinoma (HCC) varies in patients receiving transcatheter arterial chemoembolization (TACE). In this study, we aimed to assess the prognostic value of serum apolipoprotein B...
4.
Lin Z, Jiang J, Ma X, Chen J, Li H, Li X, et al.
Clin Exp Med
. 2020 Oct;
21(1):109-120.
PMID: 33037574
Transarterial chemoembolization (TACE) induces a change in serum HIF-1α level in patients with hepatocellular carcinoma (HCC). This study investigated the prognostic value of change in serum HIF-1α following TACE treatment...
5.
Wei L, Wen J, Chen J, Ma X, Wu D, Chen Z, et al.
World J Gastroenterol
. 2019 Oct;
25(37):5590-5603.
PMID: 31602160
Background: Pancreatic cancer is a major cause of cancer-related death, with a 5-year overall survival rate being below 5%. The main causes of poor prognosis in pancreatic cancer include easy...
6.
Zhao L, Yang D, Ma X, Liu M, Wu D, Zhang X, et al.
J Cancer
. 2019 Jul;
10(10):2299-2311.
PMID: 31258733
: Lymphocytes were reported to play a significant part in host anticancer immune responses and influence tumour prognosis. Few studies have focused on the prognostic values of aspartate aminotransferase (AST)...
7.
Chen Z, Zhang X, Cai X, Xie S, Liu M, Lin J, et al.
J Cancer
. 2018 Oct;
9(19):3467-3478.
PMID: 30310503
We have previously reported the prognostic value of the albumin-to-alkaline phosphatase ratio (AAPR) for advanced hepatocellular carcinoma (HCC) patients who are not receiving any standard anticancer therapy. However, the prognostic...
8.
Cai X, Chen Z, Liu M, Lin J, Zhang X, Chen J, et al.
J Cancer
. 2018 Jul;
9(13):2380-2388.
PMID: 30026834
The (CLIP) score is commonly used for prognosis prediction of hepatocellular carcinoma (HCC). The CLIP includes the Child-Pugh grade, which is relatively subjective, for hepatic encephalopathy assessment. A newly developed...
9.
Chen Z, Hong Y, Chen X, Chen J, Lin Q, Lin J, et al.
Oncol Lett
. 2018 Feb;
15(1):855-862.
PMID: 29403561
The majority of patients with unresectable hepatocellular carcinoma (HCC) undergo trans-arterial chemoembolization (TACE). However, the prognosis of HCC remains poor. In the present study, five staging systems were compared to...
10.
Nan J, Xing Y, Hu B, Tang J, Dong H, He Y, et al.
Immunology
. 2017 Dec;
154(1):144-155.
PMID: 29211299
A recent study indicated that Lectin-type oxidized LDL receptor-1 (LOX-1) was a distinct surface marker for human polymorphisms myeloid-derived suppressor cells (PMN-MDSC). The present study was aimed to investigate the...